Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk to cap insulin prices in Minnesota settlement
Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable prices that led several diabetics to ration their medications with fatal consequences.
Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes drug.
Settlement secures $35-per-month insulin for all Minnesotans
The final settlement has been reached in the state's 2018 lawsuit filed against the three largest insulin manufacturers.
Minnesota AG Reaches Another Insulin Price Cap Settlement
Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a month.
Minnesota AG announces insulin settlement
ST. PAUL, Minn. – Minnesota Attorney General Keith Ellison settled with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, guaranteeing that Minnesotans can purchase a month’s supply of Eli Lilly and Sanofi insulin products for just $35 for the next 5 years.
Novo Nordisk insulin now $35 per month for Minnesotans thanks to Attorney General Keith Ellison
Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for $35 per month.
Attorney General secures $35 Novo Nordisk insulin for Minnesotans
The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.
Novo Nordisk to cap insulin prices in Minnesota settlement
Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of deceptive pricing practices, court papers on Monday show.
Novo Norodisk caps insulin prices at $35 for Minnesotans
If you rely on insulin, you will be able to buy Novo Nordisk's products for $35 per month due to a settlement announced Monday.
KIMT
3d
All Minnesotans can now get insulin for just $35 a month
ST. PAUL, Minn. – All Minnesotans, whether they have insurance or not, will be able to buy insulin products for $35 a month ...
WJON
3d
$35 Dollar Insulin For All in Minnesota
Attorney General Keith Ellison reached a settlement with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, which ...
KSTP-TV
3d
AG Ellison expected to share ‘major’ update in lawsuit against 3 largest insulin manufacturers
Minnesota Attorney General Keith Ellison on Monday will share a major development in his lawsuit against three of the biggest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
All aboard feared dead
Los Angeles wildfire updates
Asteroid may hit Earth
Agency halts events
Signs education orders
FDA upgrades recall
Victims of DC plane crash
Blames DEI for crash
Ex-worker admits to theft
Shot dead in Sweden
Ex-FDNY chief pleads guilty
'The Voice' alum dies at 44
Searching for joyriders
US economy grew 2.3%
First spacewalk together
Gets 11 years in prison
Gun trafficking indictments
Lawsuit to keep records
KY deputy shooting sentence
Bird flu 'widespread' in MA
DOJ weighs dropping case?
Zeldin confirmed by Senate
Witkoff meets Netanyahu
Agrees to settle Trump suit
Presidential historian dies
Senate confirmation hearing
Jury weighs charges
Pushes for earlier trial
In talks to invest in OpenAI
Fall behind in reading
Hamas frees more hostages
Plans job, output cuts in US
Wildfire erupts in NC
Syria’s transitional pres
Related topics
Novo Nordisk
Keith Ellison
Feedback